Advertisement

Eye Examination for Early Detection of Diabetic Neuropathy-Role of Corneal Confocal Microscopy

  • Georgeta Victoria InceuEmail author
  • C. L. Vonica
  • G. Roman
Conference paper
Part of the IFMBE Proceedings book series (IFMBE, volume 71)

Abstract

Diabetes mellitus registers an alarming increase globally, taking epidemic proportions. Diabetic neuropathies are considered the most prevalent chronic complications of diabetes, affecting up to 50% of subjects with diabetes during lifetime. Distal symmetric polyneuropathy (DSPN), a length-dependent injury of peripheral nerves is the most frequent type among diabetic patients. Small nerve fibers are the first affected in the natural progression of the disease and their early damage can be assessed using corneal confocal microscopy (CCM). We applied CCM to the study group of 90 patients with type 2 diabetes, to identify early signs of diabetic neuropathy, to stratify patients into classes of severity of diabetic neuropathy and to find potential correlation between clinical, metabolic parameters and diabetic neuropathy severity. In our study, 88.89% of the patients were diagnosed as having DSPN, 37.77% of them with mild form, 38.88% with moderate neuropathy and 12.22% with severe neuropathy. Patients with diabetic neuropathy had a significantly higher BMI (p = 0.04) and abdominal circumference, higher HbA1c (p = 0.36) and a higher total cholesterol (p = 0.43) compared with patients without DSPN. Also, the Toronto Clinical Neuropathy Score was significantly higher in patients with pathological changes of the sub-basal corneal plexus (p = 0.04). Patients with DSPN had a significantly longer duration of diabetes (p = 0.04) and a worse glycemic control, compared with patients without DSPN. The result of our study proved that CCM can be used as a reliable diagnosis tool for early detection of small nerve fiber damage, considering that corneal sub-basal plexus changes precede clinically detected peripheral nerve changes.

Keywords

Distal symmetric polyneuropathy Corneal confocal microscopy Small nerve fibers 

Notes

Conflict of Interest

The authors declare that they have no conflict of interest.

Statement of Human and Animal Rights

The procedures involving human subjects conducted in this study were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008.

References

  1. 1.
    American Diabetes Association: Standards of medical care in diabetes-2018. Diab. Care 41(1(Suppl)), S1–S1582 (2018)Google Scholar
  2. 2.
    International Diabetes Federation: IDF Diabetes Atlas 8th Edition. International Diabetes Federation. Available at http://www.diabetesatlas.org/ (2017)
  3. 3.
    Fowler, M.J.: Microvascular and macrovascular complications of diabetes. Clin. Diab. 26(2), 77–82 (2008).  https://doi.org/10.2337/diaclin.26.2.77CrossRefGoogle Scholar
  4. 4.
    Seuring, T., Archangelidi, O., Suhrcke, M.: The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics 33(8), 811–831 (2015)CrossRefGoogle Scholar
  5. 5.
    American Diabetes Association: Economic costs of diabetes in the U.S. in 2012. Diab. Care 36(4), 1033–1046 (2013)CrossRefGoogle Scholar
  6. 6.
    Tesfaye, S., Boulton, A.J.M., Dyck, P.J., et al.: Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diab. Care 33(10), 2285–2293 (2010)CrossRefGoogle Scholar
  7. 7.
    Pop-Busui, R., Boulton, A.J., Feldman, E.L., et al.: Diabetic neuropathy: a position statement by the American diabetes association. Diab. Care 40, 136–154 (2017)CrossRefGoogle Scholar
  8. 8.
    Frykberg, R.G., Zgonis, T., Armstrong, D.G., Driver, V.R., et al.: Diabetic foot disorders. A clinical practice guideline (2006 revision). J. Foot Ankle Surg. 45(5), S1–S66 (2006)CrossRefGoogle Scholar
  9. 9.
    Boulton, A.J.M., Kirsner, R.S., Vileikyte, L.: Neuropathic diabetic foot ulcers. N. Engl. J. Med. 351, 48–55 (2004)CrossRefGoogle Scholar
  10. 10.
    Abbott, C.A., Carrington, A.L., Ashe, H., et al.: The North-West diabetes foot care study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet. Med. 19(5), 377–384 (2002)CrossRefGoogle Scholar
  11. 11.
    Lavery, L.A., Armstrong, D.G., Harkless, L.B.: Classification of diabetic foot wounds. J. Foot Ankle Surg. 35(6), 528–531 (1996)CrossRefGoogle Scholar
  12. 12.
    American Diabetes Association: Consensus Development Conference on Diabetic Foot Wound Care: 7–8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care 22(8), 354–60 (1999)Google Scholar
  13. 13.
    Brines M., Culver D.A., Ferdousi, M. et al.: Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy 8, 4734 (2018)Google Scholar
  14. 14.
    Lewis, I.J.H., Perkins, B.A., Lovblom, L.E., et al.: Using in vivo corneal confocal microscopy to identify diabetic sensorimotor polyneuropathy risk profiles in patients with type 1 diabetes. BMJ Open Diab. Res. Care 5, e000251 (2017).  https://doi.org/10.1136/bmjdrc-2016-000251CrossRefGoogle Scholar
  15. 15.
    Bril, V.: Treatments for diabetic neuropathy Journal of the Peripheral nervous. System 17, 22–27 (2012)Google Scholar
  16. 16.
    Boulton, A.J., Malik, R.A., Arezzo, J.C., et al.: Diabetic somatic neuropathies. Diab. Care 27, 1458–1486 (2004)CrossRefGoogle Scholar
  17. 17.
    Callaghan, B.C., Kerber, K.A., Lisabeth, L.L., et al.: The role of neurologists and diagnostic tests in the management of distal symmetric polyneuropathy. JAMA Neurol. 71(9), 1143–1149 (2014)CrossRefGoogle Scholar
  18. 18.
    Lauria, G., Bakkers, M., Schmitz, C., et al.: Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J. peripheral nerv. syst. 15(3), 202–207 (2010)CrossRefGoogle Scholar
  19. 19.
    Engelstad, J.K., Taylor, S.W., Witt, L.V., et al.: Epidermal nerve fibers Confidence intervals and continuous measures with nerve Conduction. Neurology 79, 2187–2193 (2012)CrossRefGoogle Scholar
  20. 20.
    Tavakoli, M., Petropoulos, I.N., Malik, R.A.: Corneal confocal microscopy to assess diabetic neuropathy: an eye on the foot. J. Diab. Sci. Technol. 7(5), 1179–1189 (2013)CrossRefGoogle Scholar
  21. 21.
    Inceu, G., Demea, H., Veresiu, I.A.: Corneal confocal microscopy—a novel, noninvasive method to assess diabetic peripheral neuropathy. Rom. J. Diab. Nutr. Metab. Dis 21(4), 319–326 (2014)Google Scholar
  22. 22.
    Tavakoli, M., Marshall, A., Pitceathly, R., et al.: Corneal confocal microscopy: a novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp. Neurol. 223(1), 245–250 (2010)CrossRefGoogle Scholar
  23. 23.
    Kemp, H.I., Petropoulos, I.N., Rice, A.S.C., et al.: Use of Corneal Confocal Microscopy to Evaluate Small Nerve Fibers in Patients With Human Immunodeficiency Virus. JAMA Ophthalmol 135(7), 795–800 (2017)CrossRefGoogle Scholar
  24. 24.
    Ferdousi, M., Azmi, S., Petropoulos, I.N., et al.: Corneal confocal microscopy detects small fibre neuropathy in patients with upper gastrointestinal cancer and nerve regeneration in chemotherapy induced peripheral neuropathy. PLoS ONE 10(10), e0139394 (2015)CrossRefGoogle Scholar
  25. 25.
    Stettner, M., Hinrichs, L., Guthoff, R. et al.: Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy. Ann. Clin. Transl. Neurol. 3(2), 88–100 (2015)Google Scholar
  26. 26.
    Maddaloni, E., Sabatino, F.: In vivo corneal confocal microscopy in diabetes: Where we are and where we can get. World J Diabetes 7(17), 406–411 (2016)CrossRefGoogle Scholar
  27. 27.
    Wang, E.F., Misram, S.L., Patel, D.V.: In: Vivo Confocal Microscopy of the Human Cornea in the Assessment of Peripheral Neuropathy and Systemic Diseases. BioMed Research International. http://dx.doi.org/10.1155/2015/951081
  28. 28.
    Malik, R.A., Kallinikos, P., Abbott, C.A., et al.: Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 46, 683–688 (2003)CrossRefGoogle Scholar
  29. 29.
    Quattrini, C., Tavakoli, M., Jeziorska, M., et al.: Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56, 2148–2154 (2007)CrossRefGoogle Scholar
  30. 30.
    Meijer, J., Smit, A., Sonderen, E., et al.: Symptom scoring systems to diagnose distal polyneuropathy in diabetes: The diabetic neuropathy symptom score. Diab. Med. 19(11), 962–965 (2002)CrossRefGoogle Scholar
  31. 31.
    Perkins, B.A., Olaleye, D., Zinman, B., Bril, V.: Simple screening tests for peripheral neuropathy in the diabetes clinic. Diab. Care 24(2), 250–256 (2001)CrossRefGoogle Scholar
  32. 32.
    Papanas, N., Ziegler, D.: Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy. Curr. Diab Rep. 13(4), 488–499 (2013)CrossRefGoogle Scholar
  33. 33.
    Jiang, M.-S., Yuan, Y., Gu, Z.-X., Zhuang, S.-L.: Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis. Br. J. Ophthalmol. 100(1), 9–14 (2016)CrossRefGoogle Scholar
  34. 34.
    Ahmed, A., Bril, V., Orszag, A., et al.: Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study. Diabetes Care 35(4), 821–828 (2012)CrossRefGoogle Scholar
  35. 35.
    Ishibashi, F., Okino, M., Ishibashi, M., et al.: Corneal nerve fiber pathology in Japanese type 1 diabetic patients and its correlation with antecedent glycemic control and blood pressure. J. Diab. Invest. 3(2), 191–198 (2012)CrossRefGoogle Scholar
  36. 36.
    Tavakoli, M., Quattrini, C., Abbott, C., et al.: Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diab. Care 33(8), 1792–1797 (2010)CrossRefGoogle Scholar
  37. 37.
    Edwards, K., Pritchard, N., Vagenas, D., et al.: Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study. Clin. Exp. Optom. 95(3), 348–354 (2012)CrossRefGoogle Scholar
  38. 38.
    Tavakoli, M., Kallinikos, P.A., Efron, N., et al.: Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes. Diab. Care 30(7), 1895–1897 (2007)CrossRefGoogle Scholar
  39. 39.
    Petropoulos, I.N., Alam, U., Fadavi, H., et al.: Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diab. Care 36(11), 3646–3651 (2013)CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Georgeta Victoria Inceu
    • 1
    Email author
  • C. L. Vonica
    • 1
  • G. Roman
    • 1
    • 2
  1. 1.“Iuliu Hatieganu” University of Medicine and PharmacyCluj-NapocaRomania
  2. 2.Clinical Center of Diabetes, Nutrition, Metabolic DiseasesCluj-NapocaRomania

Personalised recommendations